• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: COVID-19

Effectiveness of COVID boosters in MS: an update

November 30, 2022  

ECTRIMS 2022 HIGHLIGHTS – SATURDAY, OCTOBER 29 EDITION

October 29, 2022  

ECTRIMS 2022 HIGHLIGHTS – THURSDAY, OCTOBER 27 EDITION

October 27, 2022  

Bivalent COVID booster approved in Canada

September 16, 2022  

COVID-19 and MS – updated findings

July 28, 2022  

COVID update: the 7th wave

July 13, 2022  

Key changes in Canadian MS care during the pandemic

July 7, 2022  

Pandemic prescribing – what changed?

July 6, 2022  

EAN 2022 HIGHLIGHTS – THURSDAY, JUNE 30 EDITION

June 30, 2022  

EAN 2022 HIGHLIGHTS – TUESDAY, JUNE 28 EDITION

June 28, 2022  
1
2
3
Next

Browse by Topic

  • EPILEPSY (37)
  • ECTRIMS 2025 (7)
  • MS (426)
  • BIOMARKERS IN MS (60)
  • Library (18)
  • CLINICAL CASES IN MS (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • ECTRIMS 2025 HIGHLIGHTS – FRIDAY, SEPTEMBER 26, 2025 posted on September 26, 2025
  • CNS effects of Wegovy (semaglutide) posted on February 28, 2023
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions